Table 3.
Plasma clearance (CL/F) of VPA and formation clearances to various urinary metabolites.
Clearance | Day 7 | Day 21 | Mean difference | 95% CI |
---|---|---|---|---|
Plasma VPA (ml kg−1 h−1) | 6.17 ± 1.50 | 7.30 ± 2.33 | −1.13 | −2.20 to −0.636 * |
VPA-glucuronide (ml kg−1 h−1) | 0.534 ± 0.145 | 0.505 ± 0.182 | 0.029 | −0.062–0.121 |
E-2-en-VPA (ml kg−1 h−1) | 0.010 ± 0.009 | 0.024 ± 0.016 | −0.014 | −0.025 to −0.004 * |
3-oxo-VPA (ml kg−1 h−1) | 2.57 ± 0.75 | 3.60 ± 1.47 | −1.03 | −1.72 to −0.339 * |
4-OH-VPA (ml kg−1 h−1) | 0.112 ± 0.046 | 0.110 ± 0.074 | 0.0021 | −0.038–0.042 |
Unaccounted for (ml kg−1 h−1) | 2.96 ± 1.50 | 3.07 ± 1.81 | −0.108 | −1.25–1.03 |
Clearances over a steady state interdosing interval from 08.00 to 20.00 h, mean ± s.d., n = 12.
95% CI excludes zero.